Antimicrobial Surface-Coating from Irish Company Kastus® is Shown to be Effective Against the Human Coronavirus on Treated Glass and Ceramic Surfaces

A leading antimicrobial surface-coating from Irish company Kastus® is shown to be effective against the human coronavirus on treated glass and ceramic surfaces.

A patented surface-coating technology developed by Irish company Kastus® is shown to be effective against human coronavirus on treated surfaces, an independent Global testing laboratory has confirmed.

Founded in 2014, this pioneering antimicrobial surface-coating technology has a far reaching impact across a wide range of consumer brands and industries, and can be applied across everything from smartphones and touchscreen kiosks to screen protectors and ceramic tiles.

Kastus has previously been proven to block up to 99.99 per cent of surface bacteria and fungi including antibiotic-resistant superbugs such as MRSA and E. coli. Now new independent testing conducted by a leading Global test laboratory has confirmed that the Kastus technology is effective against human coronavirus on coated surfaces.

The Kastus coating is applied and baked in to the top layer of the glass or ceramics surface during the manufacturing process. Once it’s locked in, the Kastus coating is constantly working to help protect the underlying touchscreen device, glass, or ceramic surface, while its antimicrobial power is always on through the lifetime of the product.

“With this new validation and testing, we’re giving brands and commercial partners across the globe a solution that they can build into their products to get industry back on its feet again”, said company chief executive John Browne. “Our unique technology is particularly relevant to those businesses who use shared touchscreens and devices, helping to mitigate the spread of the virus, while addressing consumer concerns and reluctancy to use public touchscreens.”

While the Kastus coating is primarily designed for use on new products, companies can retrospectively add screen protectors with the coating applied to help provide enhanced protection, meaning it could soon be widely available across products such as touchscreen kiosks in restaurants, shopping centres and airports.

Kastus, who won the Irish Times overall Innovation award in 2017, is supported by backers that include Atlantic Bridge and Ascent Capital. The company is currently in the process of targeting a Series B funding round reflecting its intentions to more than double staff numbers to 50 people.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kastus. (2020, June 16). Antimicrobial Surface-Coating from Irish Company Kastus® is Shown to be Effective Against the Human Coronavirus on Treated Glass and Ceramic Surfaces. AZoM. Retrieved on November 24, 2024 from https://www.azom.com/news.aspx?newsID=53759.

  • MLA

    Kastus. "Antimicrobial Surface-Coating from Irish Company Kastus® is Shown to be Effective Against the Human Coronavirus on Treated Glass and Ceramic Surfaces". AZoM. 24 November 2024. <https://www.azom.com/news.aspx?newsID=53759>.

  • Chicago

    Kastus. "Antimicrobial Surface-Coating from Irish Company Kastus® is Shown to be Effective Against the Human Coronavirus on Treated Glass and Ceramic Surfaces". AZoM. https://www.azom.com/news.aspx?newsID=53759. (accessed November 24, 2024).

  • Harvard

    Kastus. 2020. Antimicrobial Surface-Coating from Irish Company Kastus® is Shown to be Effective Against the Human Coronavirus on Treated Glass and Ceramic Surfaces. AZoM, viewed 24 November 2024, https://www.azom.com/news.aspx?newsID=53759.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.